Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris

NCT00750152 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Cruris
Jock Itch

Interventions

DRUG: NAFT-500
DRUG: Placebo

Sponsor

Merz North America, Inc.